Downs Christopher 4
4 · CNS Pharmaceuticals, Inc. · Filed Aug 23, 2023
Insider Transaction Report
Form 4
Downs Christopher
Chief Financial Officer
Transactions
- Purchase
Common Stock
2023-08-22$1.27/sh+27,000$34,177→ 36,772 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $1.2196 to $1.2999. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.